文献速递糖尿病

糖尿病与无糖尿病患者预防性植入式心律转复除颤器适当电击与死亡率的比较

Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators.
PubMed 文献 · Diabetes Care · 2019-10-23

基于EU-CERT-ICD回顾性注册研究,纳入3535例预防性植入ICD患者,其中995例(28%)有糖尿病史。随访3.2±2.3年,糖尿病与较低适当电击风险相关(校正HR 0.77,95%CI 0.62-0.96,P=0.02),但全因死亡率显著更高(校正HR 1.30,95%CI 1.11-1.53,P=0.001)。提示糖尿病患者的超额死亡可能并非主要由室性快速性心律失常所致。

要点

  • 预防性ICD患者中,糖尿病与适当电击风险降低相关(校正HR 0.77)。
  • 糖尿病患者全因死亡率显著高于无糖尿病者(校正HR 1.30)。
  • 糖尿病患者的超额死亡可能并非主要源于室性快速性心律失常。

核心结论

  • 糖尿病患者预防性ICD后全因死亡率高于无糖尿病者,但适当电击发生率更低,提示超额死亡可能非主要由室性快速性心律失常引起。

研究设计与样本

  • 回顾性EU-CERT-ICD注册研究,纳入12个欧洲中心3535例因 primary SCD 预防植入ICD的患者,平均年龄63.7±11.2岁(82%男性),995例(28%)有糖尿病史。

主要发现

  • 糖尿病与适当电击风险降低相关(校正HR 0.77,95%CI 0.62-0.96,P=0.02)。
  • 糖尿病与全因死亡率升高相关(校正HR 1.30,95%CI 1.11-1.53,P=0.001)。
  • 平均随访时间3.2±2.3年。

临床怎么用

  • 对合并糖尿病的预防性ICD患者,应关注非心律失常性死亡原因,优化整体管理。

局限性

  • 回顾性注册研究设计,可能受混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diabetes increases the risk of all-cause mortality and sudden cardiac death (SCD). The exact mechanisms leading to sudden death in diabetes are not well known. We compared the incidence of appropriate shocks and mortality in patients with versus without diabetes with a prophylactic implantable cardioverter defibrillator (ICD) included in the retrospective EU-CERT-ICD registry. RESEARCH DESIGN AND METHODS AND RESULTS: A total of 3,535 patients from 12 European EU-CERT-ICD centers with a mean age of 63.7 ± 11.2 years (82% males) at the time of ICD implantation were included in the analysis. A total of 995 patients (28%) had a history of diabetes. All patients had an ICD implanted for primary SCD prevention. End points were appropriate shock and all-cause mortality. Mean follow-up time was 3.2 ± 2.3 years. Diabetes was associated with a lower risk of appropriate shocks (adjusted hazard ratio [HR] 0.77 [95% CI 0.62-0.96], P = 0.02). However, patients with diabetes had significantly higher mortality (adjusted HR 1.30 [95% CI 1.11-1.53], P = 0.001). CONCLUSIONS: All-cause mortality is higher in patients with diabetes than in patients without diabetes with primary prophylactic ICDs. Subsequently, patients with diabetes have a lower incidence of appropriate ICD shocks, indicating that the excess mortality might not be caused primarily by ventricular tachyarrhythmias. These findings suggest a limitation of the potential of prophylactic ICD therapy to improve survival in patients with diabetes with impaired left ventricular function.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Junttila MJ, Pelli A, Kenttä TV, et al. Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators. Diabetes Care. 2019. PMID: 31645407. doi:10.2337/dc19-1014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。